You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Based on genome data for 3,010 Asian rice accessions, researchers retraced the domestication history and diversity of Xian/Indica and Geng/Japonica rice.
This week's news includes Danaher, BGI, Mobadiag, and Sygnis.
The partners plan to share information about joint R&D activities and establish research facilities and laboratory infrastructure in Ethiopia.
In a study published in PLOS One last month, the researchers compared results from the BGISEQ-500 and the Illumina HiSeq X Ten for tumor and germline samples from three patients.
BGI has ordered 10 Sequel systems to meet long-read sequencing demand for bacterial, plant, and animal de novo, transcriptome, and epigenomics sequencing.
The Chinese government has implemented clearer regulatory guidance for genomic tests and invested in both clinical testing and research, spurring growth.
Along with sequencing and resequencing on orphan crop plants, the team is providing professional development to spur genomics-assisted plant breeding in Africa.
Among the firms reporting, BGI talked about plans to cut down the time and cost of its WGS service, and Invitae's CEO made a surprising proclamation about genetic testing.
The firms plan to integrate Curetis' Unyvero sample prep system and MGI's NGS to create a microbial pathogens and antibiotic resistance detection workflow.
The China Food and Drug Administration had also previously accredited both the NIFTY test and the BGISEQ sequencing platform.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.